Naloxone's anorectic effect is dependant upon the relative palatability of food

https://doi.org/10.1016/0091-3057(93)90222-FGet rights and content

Abstract

It has been suggested that opioids modify food intake by enhancing palatability. In the present series of studies we evaluated the effect of naloxone on food intake of a preferred food (chocolate chip cookies), normal rat chow, and an “aversive” food (high fiber chow). We found that naloxone decreased 18- and 48-h deprivation-induced intake of chocolate chip cookies much more potently than that of chow, when these foods were presented on separate occasions. When these foods were presented concurrently, this difference in naloxone's potency was no longer apparent. When rats were offered high fiber chow, only the 10 mg/kg dose of naloxone decreased intake. In these same rats naloxone significantly decreased normal chow intake at a dose of 0.1 mg/kg. Thus, naloxone's ability to decrease food intake appears to be dependent upon the palatability of the food.

References (24)

Cited by (95)

  • Involvement of opioid signaling in food preference and motivation: Studies in laboratory animals

    2016, Progress in Brain Research
    Citation Excerpt :

    Most of these have focused on dietary restraint access by disrupting food intake through restrictions of caloric availability, limiting duration of food access, combining access to food with environmental stress, and intermittingly offering sugar and chow, and each has shown these to be crucial in instigating binge-like behavior (Corwin and Buda-Levin, 2004; Geary, 2003; Giraudo et al., 1993; Hagan et al., 2002, 2003; Howard and Porzelius, 1999; Inoue et al., 2004). Studies using a variety of binge-eating-like behavior models have consistently shown that opioid receptor antagonists, particularly those acting on mu-opioid receptors, reduce or attenuate the expression of binge-like food consumption in animals (Barbano and Cador, 2006; Bodnar et al., 1995; Cooper, 1980; Davis et al., 1983; Giraudo et al., 1993; Glass et al., 2001; Hadjimarkou et al., 2004; Hagan et al., 1997; Kelley et al., 1996; Levine and Billington, 1997). It is still debated whether eating disorders can be thought of as food addictions (Salamone and Correa, 2013) as contention still exists about how the neural signatures of eating disorders are similar to the neuroadaptations that take place in the development of drug addiction (Ifland et al., 2009; Pelchat, 2009; Rogers and Smit, 2000).

  • Generating positive affective states in sheep: The influence of food rewards and opioid administration

    2014, Applied Animal Behaviour Science
    Citation Excerpt :

    In contrast, administration of naloxone (an opioid antagonist) decreases food intake in rats (Giraudo et al., 1993) and sheep (Alavi et al., 1993, 1991; Verbeek et al., 2012), and is thought to reduce the rewarding properties of palatable foods (Glass et al., 1996). Naloxone has no effect on unpalatable food consumption, except at very high doses (Giraudo et al., 1993; Glass et al., 1996). Previously we have shown that morphine increases locomotor activity and vocalisations in sheep, suggesting that it increases the arousal component of affective states (Verbeek et al., 2012).

  • Principles of motivation revealed by the diverse functions of neuropharmacological and neuroanatomical substrates underlying feeding behavior

    2013, Neuroscience and Biobehavioral Reviews
    Citation Excerpt :

    Systemic administration of opioid agonists increases, and of antagonists decreases, food intake in sated rats (Glass et al., 1999; Bodnar, 2004; Levine and Billington, 2004). Moreover, opioid antagonists, such as naloxone or naltrexone, preferentially decrease the intake of highly palatable, sweet, or fatty foods (Giraudo et al., 1993; Agmo et al., 1995; Cleary et al., 1996; Yeomans and Gray, 1997, 2002; Glass et al., 1999; Kelley et al., 2002; Barbano and Cador, 2005) while opioid agonists, such as morphine or DAMGO, preferentially increase it (Bakshi and Kelley, 1993; Doyle et al., 1993; Zhang and Kelley, 1997). As well, Barbano and Cador (2005) found that the amount of food eaten in sated or restricted rats is not modified after systemic injection of a dopaminergic antagonist (alpha-flupentixol), whatever the degree of palatability of the food and whatever the doses of the neuroleptic used (though these doses were devoid of motor-debilitating effects).

View all citing articles on Scopus
View full text